{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Myriad Genetics, Inc."},"Symbol":{"label":"Symbol","value":"MYGN"},"Address":{"label":"Address","value":"320 WAKARA WAY, SALT LAKE CITY, Utah, 84108, United States"},"Phone":{"label":"Phone","value":"+1 801 584-3600"},"Industry":{"label":"Industry","value":"Biotechnology: In Vitro & In Vivo Diagnostic Substances"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Prequel, with is a noninvasive prenatal test; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies."},"CompanyUrl":{"label":"Company Url","value":"https://www.myriad.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Dale Muzzey","title":"Chief Scientific Officer"},{"name":"Kevin R. Haas","title":"Chief Technology Officer"},{"name":"Paul J. Diaz","title":"President, Chief Executive Officer & Director"},{"name":"Samraat S Raha","title":"Chief Operating Officer"},{"name":"Thomas P. Slavin","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}